Decoding the functional specificity of E2F3 isoforms
Related Experiment Video
Updated: Nov 5, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
1Institute of Clinical Sciences, Imperial College London, London W12 0HS, UK.
Abstract:
E2F3 is a central regulator of cell cycle progression, development, differentiation, and oncogenesis. Alternative promoter usage generates two major homologous isoforms, E2F3A and E2F3B, differing only at their N-termini. Although E2F3A is traditionally considered an activator and E2F3B a repressor of transcription, studies suggest that both isoforms have overlapping and isoform-specific functions, shaped by differences in temporal expression, protein stability, and target gene specificity. In this review, we examine how E2F3A and E2F3B contribute to proliferation, differentiation, and cancer. We also discuss contradictions and limitations in experimental approaches that have complicated the interpretation of these functions. Finally, we explore how clarifying these roles could help resolve long-standing questions in cell cycle regulation, differentiation, and cancer, where E2F3 plays a major role.
Related Concept Videos
Master Transcription Regulators
General Transcription Factors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Cell Specific Gene Expression
Transcription Factors
RNA Polymerase II Accessory Proteins

